Last reviewed · How we verify
NCT06809647
A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma
NA trial testing Glaucoma surgery in Glaucoma Open-Angle in 10 participants. Not yet recruiting.
30 June 2026
Quick facts
| Lead sponsor | PLU Ophthalmic |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 30 March 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 August 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Glaucoma surgery
Conditions studied
- Glaucoma Open-Angle — all drugs for Glaucoma Open-Angle →
Sponsor
PLU Ophthalmic
Who can join
18 and older, any sex, with Glaucoma Open-Angle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will follow a group of patients with glaucoma disease that undergo a surgical procedure intended to reduce the intra-ocular pressure (IOP) for a period of one year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06809647
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Glaucoma surgery
Trials testing the same drug.
- NCT03613233 — QoL Assessment in Traditional Glaucoma Surgery and MIGS. · NA · unknown
Other recruiting trials for Glaucoma Open-Angle
Currently open trials in the same condition.
- NCT06685211 — Electrical Stimulation for Vision Neuroenhancement in Glaucoma · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06809647 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PLU Ophthalmic
- Last refreshed: 5 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06809647.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing